Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship: Priority Announcement - Clinical Nutrition

McMaster University

$55,000.00

Efficacy of exclusive enteral nutrition to induce clinical remission in patients with Crohn's disease: A multidimensional assessment to investigate potential mechanisms.

EF 2016-17

Résumé
Crohn's disease (CD) is an incurable inflammatory bowel disease (IBD) characterised by inflammation in the gut which leads to diarrhoea, abdominal pain and gut bleeding. There are multiple options for treatment including steroids, which are often associated with severe side effects. The administration of a formula for exclusive feeding (EEN) is well-established as an alternative to steroids in children with Crohn's disease. However, other than in Japanese populations, this intervention is not routinely used in adults because of controversial results in some studies. In fact, only a few studies have examined the effects of enteral feeding in adult patients with CD. We propose that polymeric formulas, provided orally, may help decrease gut inflammation and improve nutritional status through modulation of gut bacteria. We will therefore investigate the effect of exclusive formula feeding therapy in adult patients with active CD, on symptoms and inflammation after 6-8 weeks of treatment. We will collect information through questionnaires that assess gut symptoms, quality of life, mood changes and dietary patterns. To investigate potential mechanisms we will collect stool samples to characterize gut bacterial profiles, blood to determine inflammatory markers and evaluate gut movements (motility) before, after the treatment. We hope that our results will lead to better understanding of the beneficial effect of exclusive formula feeding in CD as a safer option than steroids, and to understand the mechanisms of this therapy.
Programme
Fellowship: Priority Announcement - Clinical Nutrition
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
363763
Name
Pinto-Sanchez Maria I
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Nutrition Society (Ottawa, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Health systems / services
Prcname2
Health Research Training B - HP
Projecttitle
Efficacy of exclusive enteral nutrition to induce clinical remission in patients with Crohn's disease: A multidimensional assessment to investigate potential mechanisms.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$55,000
Cihrequipment2
$0
Programname2
Fellowship: Priority Announcement - Clinical Nutrition
Keyworddelim
Crohn'S Disease; Exclusive Enteral Nutrition; Microbiota; Motility; Mucosal Healing; Nutrition
Abstract
Crohn's disease (CD) is an incurable inflammatory bowel disease (IBD) characterised by inflammation in the gut which leads to diarrhoea, abdominal pain and gut bleeding. There are multiple options for treatment including steroids, which are often associated with severe side effects. The administration of a formula for exclusive feeding (EEN) is well-established as an alternative to steroids in children with Crohn's disease. However, other than in Japanese populations, this intervention is not routinely used in adults because of controversial results in some studies. In fact, only a few studies have examined the effects of enteral feeding in adult patients with CD. We propose that polymeric formulas, provided orally, may help decrease gut inflammation and improve nutritional status through modulation of gut bacteria. We will therefore investigate the effect of exclusive formula feeding therapy in adult patients with active CD, on symptoms and inflammation after 6-8 weeks of treatment. We will collect information through questionnaires that assess gut symptoms, quality of life, mood changes and dietary patterns. To investigate potential mechanisms we will collect stool samples to characterize gut bacterial profiles, blood to determine inflammatory markers and evaluate gut movements (motility) before, after the treatment. We hope that our results will lead to better understanding of the beneficial effect of exclusive formula feeding in CD as a safer option than steroids, and to understand the mechanisms of this therapy.
Competitiondate
201611
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Pinto-Sanchez, Maria I
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $55,000~ $0~